Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging

Sheba Medical Center100 enrolled

Overview

This research aims to investigate the correlation between tumor temperature difference and biological factors, such as size, metabolism, treatment response, and tumor aggressiveness. In addition, normal tissue response to radiation therapy in treated organ will be evaluated.

Study Type

INTERVENTIONAL

Allocation

Masking

NONE

Enrollment

100

Conditions

MALIGNANCY

Interventions

THERMOGRAPHY IMAGINGRADIATION

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * signed informed consent * biopsy proven cervical cancer which will undergo definitive radiation Exclusion Criteria: * not eligible to sign informed consent

Outcomes

Primary Outcomes

The change in Infra-Red radiation emitted at wavelengths 0.8-1nm

Measurement of IR

Time frame: Baseline and 4 weeks

Secondary Outcomes

Evaluating of efficacy of the radiation

The thermal and the optic imaging will be taken and analyzed in order to evaluate the changing in the temperature of the cervix comparing to the baseline as the indication of the response to the radiotherapy

Time frame: 3 months after the treatment

Central Contacts

Tatiana Rabin, MD

CONTACT

972-tatiana.rabin@sheba.health.gov.il

Zvi Symon, MD

CONTACT

972 zvi.symon@sheba.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.